Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...
Proteinuria is a condition characterised by the presence of excess protein, mainly albumin, in the urine. Generally, the kidneys filter waste products and excess fluids from the blood and excrete them ...
Clinical Trials Arena on MSN
Boehringer Ingelheim’s kidney drug reduces proteinuria by 40% in Phase II trial
Data from Boehringer Ingelheim’s Phase II apecotrep study was published in The Lancet and presented at the 2025 ASN’s Kidney Week ...
Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, ...
Vertex is running a phase 2 trial of inaxaplin in APOL1-mediated kidney diseases, including some forms of FSGS. The phase 3 ...
A 74-year-old man with chronic kidney disease (CKD) and type 2 diabetes presented to our nephrology clinic for follow-up of diabetic kidney disease with a serum creatinine of 180 (reference range 59 ...
Background The long-term trajectories of estimated glomerular filtration rate (eGFR) and their relation to early proteinuria ...
February 16, 2010 — Proteinuria may help predict outcomes in chronic kidney disease (CKD) independent of estimated glomerular filtration rate (eGFR) level, according to the results of a ...
German family-owned pharma major Boehringer Ingelheim today announced results from a Phase II trial evaluating apecotrep (BI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results